Drilldown: Medicines
Medicines > classes 
:
Anticonvulsant or
Antiparkinsonian or
[[:Category:Antimigraine medicines|Antimigraine medicine]]
:
Anticonvulsant or
Antiparkinsonian or
[[:Category:Antimigraine medicines|Antimigraine medicine]] Use the filters below to narrow your results.
generic:
Amantadine (1) ·
Apomorphine (1) ·
Benztropine (1) ·
Biperiden (1) ·
Brivaracetam (1) ·
Bromocriptine (1) ·
Cabergoline (1) ·
Cannabidiol (1) ·
Carbidopa/levodopa (1) ·
Cenobamate (1) ·
Clobazam (1) ·
Entacapone (1) ·
Eslicarbazepine (1) ·
Ethosuximide (1) ·
Felbamate (1) ·
Fenfluramine (1) ·
Fosphenytoin (1) ·
Lacosamide (1) ·
Levodopa (1) ·
Opicapone (1) ·
Perampanel (1) ·
Phenobarbital (1) ·
Phenytoin (1) ·
Rasagiline (1) ·
Rimegepant (1) ·
Rizatriptan (benzoate) (1) ·
Rotigotine (1) ·
Rufinamide (1) ·
Safinamide (1) ·
Selegiline (1) ·
Stiripentol (1) ·
Sumatriptan (succinate) (1) ·
Tiagabine (1) ·
Tolcapone (1) ·
Trihexyphenidyl (1) ·
Valproic acid (1) ·
Vigabatrin (1) ·
Zonisamide (1)
brand:
None (1) ·
Akineton (1) ·
Apokyn (1) ·
Aptiom (1) ·
Artane (1) ·
Azilect (1) ·
Banzel (1) ·
Briviact (1) ·
Cerebyx (1) ·
Cogentin (1) ·
Comtan (1) ·
Depakote (1) ·
Diacomit (1) ·
Dilantin (1) ·
Dostinex (1) ·
Eldepryl (1) ·
Epidiolex (1) ·
Felbatol (1) ·
Fintepla (1) ·
Fycompa (1) ·
Gabitril (1) ·
Imitrex (oral, injectable, nasal), Tosymra (nasal spray), Onzetra Xsail (nasal powder), Zembrace SymTouch (low-dose autoinjector), Sumavel DosePro (needle-free SC) (1) ·
Luminal (1) ·
Maxalt (tablet), Maxalt-MLT (orally disintegrating tablet) (1) ·
Neupro (1) ·
Nurtec ODT (1) ·
Onfi (1) ·
Ongentys (1) ·
Parlodel (1) ·
Sabril (1) ·
Sinemet (1) ·
Symmetrel (1) ·
Tasmar (1) ·
Vimpat (1) ·
Xadago (1) ·
Xcopri (1) ·
Zarontin (1) ·
Zonegran (1)
classes: (Click arrow to add another value)
mechanism:
None (3) ·
AMPA receptor antagonist (1) ·
Central and peripheral COMT inhibitor (1) ·
D1/D2/D3 receptor agonist (1) ·
D2 agonist; D1 partial agonist (1) ·
D2 receptor agonist (1) ·
Dopamine precursor (1) ·
Dopamine precursor + DOPA decarboxylase inhibitor (1) ·
GABA enhancer; sodium channel blocker; histone deacetylase inhibitor (1) ·
GABA reuptake inhibitor (GAT-1 blocker) (1) ·
GABAA positive allosteric modulator (1) ·
GABAA positive allosteric modulator; lactate dehydrogenase inhibitor (1) ·
GABAA potentiator and direct activator (1) ·
Irreversible GABA-T inhibitor (1) ·
Irreversible selective MAO-B inhibitor (2) ·
MAO-B inhibitor; sodium channel blocker; glutamate release inhibitor (1) ·
Multiple mechanisms; GPR55 antagonist; TRPV1 agonist (1) ·
Muscarinic receptor antagonist (1) ·
Muscarinic receptor antagonist; dopamine reuptake inhibitor (1) ·
NMDA antagonist; dopamine releasing agent (1) ·
NMDA antagonist; GABAA potentiator (1) ·
Non-selective dopamine receptor agonist (1) ·
Once-daily COMT inhibitor (1) ·
Peripheral COMT inhibitor (1) ·
Prodrug of phenytoin; sodium channel blocker (1) ·
Selective M1 muscarinic antagonist (1) ·
Serotonin releaser; sigma-1 agonist (1) ·
Slow-inactivation sodium channel enhancer; CRMP-2 ligand (1) ·
Sodium channel blocker (2) ·
Sodium channel blocker; GABAA positive allosteric modulator (1) ·
Sodium channel modulator (1) ·
Sodium/T-type calcium channel blocker; carbonic anhydrase inhibitor (1) ·
SV2A ligand (higher affinity than levetiracetam) (1) ·
T-type calcium channel blocker (1)
uses:
starting dose:
None (35) ·
5-10 mg PO at migraine onset; may repeat after 2 hours, maximum 30 mg/24 hours (1) ·
Acute migraine: 75 mg PO at onset, maximum one dose per 24 hours. Preventive: 75 mg PO every other day (1) ·
Oral: 50-100 mg at migraine onset, may repeat in 2 hours if needed. SC: 6 mg, may repeat in 1 hour. Nasal: 5-20 mg per nostril, may repeat in 2 hours (1)
preparations:
None (35) ·
Oral tablets 25, 50, 100 mg; SC injection 4, 6 mg autoinjector; needle-free SC 6 mg (Sumavel); nasal spray 5, 20 mg; nasal powder 22 mg (Onzetra Xsail); low-dose autoinjector 3 mg (Zembrace SymTouch) (1) ·
Orally disintegrating tablet 75 mg (1) ·
Tablets 5, 10 mg; ODT (Maxalt-MLT) 5, 10 mg (1)
fda max:
routes:
onset:
duration:
halflife:
bioavailability:
pregnancy:
None (35) ·
Limited human data.<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed|citation needed]]]</sup> (1) ·
Limited human data; pregnancy registry data have been broadly reassuring across the triptan class.<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed|citation needed]]]</sup> (1) ·
Limited human data; pregnancy registry data have been broadly reassuring relative to baseline malformation rates.<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed|citation needed]]]</sup> (1)
Showing below up to 38 results in range #1 to #38.